ATE342901T1 - Bicyclische, stickstoffhaltige heterocyclische derivate zur verwendung als antibakterielle mittel - Google Patents

Bicyclische, stickstoffhaltige heterocyclische derivate zur verwendung als antibakterielle mittel

Info

Publication number
ATE342901T1
ATE342901T1 AT02774022T AT02774022T ATE342901T1 AT E342901 T1 ATE342901 T1 AT E342901T1 AT 02774022 T AT02774022 T AT 02774022T AT 02774022 T AT02774022 T AT 02774022T AT E342901 T1 ATE342901 T1 AT E342901T1
Authority
AT
Austria
Prior art keywords
antibacterial agents
nitrogen heterocyclic
heterocyclic derivatives
bicyclic nitrogen
derivatives
Prior art date
Application number
AT02774022T
Other languages
English (en)
Inventor
Catherine Genevieve Yv Dartois
Roger Edward Markwell
Guy Marguerite Marie Ge Nadler
Neil David Pearson
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of ATE342901T1 publication Critical patent/ATE342901T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT02774022T 2001-05-25 2002-05-24 Bicyclische, stickstoffhaltige heterocyclische derivate zur verwendung als antibakterielle mittel ATE342901T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0112836.2A GB0112836D0 (en) 2001-05-25 2001-05-25 Medicaments

Publications (1)

Publication Number Publication Date
ATE342901T1 true ATE342901T1 (de) 2006-11-15

Family

ID=9915344

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02774022T ATE342901T1 (de) 2001-05-25 2002-05-24 Bicyclische, stickstoffhaltige heterocyclische derivate zur verwendung als antibakterielle mittel

Country Status (8)

Country Link
US (1) US7186730B2 (de)
EP (1) EP1392686B1 (de)
JP (1) JP2004534780A (de)
AT (1) ATE342901T1 (de)
DE (1) DE60215494T2 (de)
ES (1) ES2275006T3 (de)
GB (1) GB0112836D0 (de)
WO (1) WO2002096907A1 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6803369B1 (en) 2000-07-25 2004-10-12 Smithkline Beecham Corporation Compounds and methods for the treatment of neoplastic disease
IL154107A0 (en) 2000-07-26 2003-07-31 Smithkline Beecham Plc Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
WO2002024684A1 (en) * 2000-09-21 2002-03-28 Smithkline Beecham P.L.C. Quinoline derivatives as antibacterials
GB0031088D0 (en) * 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
GB0031086D0 (en) * 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
GB0101577D0 (en) * 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0112836D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0118238D0 (en) * 2001-07-26 2001-09-19 Smithkline Beecham Plc Medicaments
AU2003239302A1 (en) * 2002-01-29 2003-09-02 Glaxo Group Limited Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
WO2003064421A1 (en) * 2002-01-29 2003-08-07 Glaxo Group Limited Aminopiperidine derivatives
TW200409637A (en) 2002-06-26 2004-06-16 Glaxo Group Ltd Compounds
TW200406413A (en) * 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
AU2003303956A1 (en) * 2002-11-05 2004-11-23 Smithkline Beecham Corporation Antibacterial agents
AU2003291227A1 (en) 2002-11-05 2004-06-07 Smithkline Beecham Corporation Antibacterial agents
CA2581057A1 (en) * 2004-10-05 2006-04-13 Actelion Pharmaceuticals Ltd New piperidine antibiotics
EP1846411A4 (de) 2005-01-25 2010-08-04 Glaxo Group Ltd Antibakterielle wirkstoffe
US7709472B2 (en) * 2005-01-25 2010-05-04 Glaxo Group Limited Antibacterial agents
JP2008528588A (ja) 2005-01-25 2008-07-31 グラクソ グループ リミテッド 抗菌剤
JP2008528586A (ja) 2005-01-25 2008-07-31 グラクソ グループ リミテッド 抗菌剤
WO2006081264A1 (en) 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
AU2006335042A1 (en) * 2005-10-21 2007-07-19 Glaxo Group Limited Compounds
ES2344523T3 (es) 2005-12-22 2010-08-30 Glaxo Group Limited Compuestos heterociclicos, su preparacion y su uso como agentes antibacterianos.
US20070265270A1 (en) * 2006-02-21 2007-11-15 Hitchcock Stephen A Cinnoline derivatives as phosphodiesterase 10 inhibitors
US20070287707A1 (en) * 2006-02-28 2007-12-13 Arrington Mark P Phosphodiesterase 10 inhibitors
JP2009529060A (ja) * 2006-03-08 2009-08-13 アムゲン インコーポレイティッド ホスホジエステラーゼ１０阻害剤としてのキノリン及びイソキノリン誘導体
ATE481406T1 (de) 2006-04-06 2010-10-15 Glaxo Group Ltd Pyrrolochinoxalinonderivate als antibakterielle mittel
EP2007377A4 (de) 2006-04-06 2011-08-17 Glaxo Group Ltd Antibakterielle wirkstoffe
GB0608263D0 (en) 2006-04-26 2006-06-07 Glaxo Group Ltd Compounds
SG164384A1 (en) * 2006-05-26 2010-09-29 Toyama Chemical Co Ltd Novel heterocyclic compound or salt thereof and intermediate thereof
GB0613208D0 (en) 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
EP1992628A1 (de) 2007-05-18 2008-11-19 Glaxo Group Limited Derivate und Analoge von N-Ethylquinolonen und N-Ethylazaquinolonen
CL2008001002A1 (es) * 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
CL2008001003A1 (es) * 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
JP5389013B2 (ja) * 2007-04-20 2014-01-15 グラクソ グループ リミテッド 抗菌剤としての三環式含窒素化合物
AU2008249745B2 (en) 2007-05-09 2012-01-12 Pfizer Inc. Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials
JP5323088B2 (ja) * 2007-12-18 2013-10-23 アクテリオン ファーマシューティカルズ リミテッド ５−アミノシクリルメチル−オキサゾリジン−２−オン誘導体
EP2080761A1 (de) 2008-01-18 2009-07-22 Glaxo Group Limited Verbindungen
BRPI0916571A2 (pt) * 2008-08-04 2015-11-10 Actelion Pharmaceuticals Ltd composto derivado de alquilaminometiloxazolidinona tricíclo, medicamento e composição farmacêutica que o contém e uso do composto
EP2352734A1 (de) 2008-10-17 2011-08-10 Glaxo Group Limited Als antibakterielle mittel verwendete tricyclische stickstoffverbindungen
JP5653935B2 (ja) 2009-01-15 2015-01-14 グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ 抗菌薬として有用なナフチリジン―２（１ｈ）−オン化合物
AR089929A1 (es) 2012-02-10 2014-10-01 Actelion Pharmaceuticals Ltd Proceso para manufacturar un derivado de naftiridina
EP3639824A1 (de) 2014-08-22 2020-04-22 GlaxoSmithKline Intellectual Property Development Limited Tricyclische stickstoffhaltige verbindungen zur behandlung einer infektion mit neisseria gonorrhoea
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
WO2021076886A1 (en) 2019-10-18 2021-04-22 The Regents Of The University Of California 3-phenylsulphonyl-quinoline derivatives as agents for treating pathogenic blood vessels disorders

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US646144A (en) * 1899-12-16 1900-03-27 Thomas W Gardiner Last.
NL7908031A (nl) * 1979-11-01 1981-06-01 Acf Chemiefarma Nv Nieuwe chinolinederivaten en farmaceutische preparaten die een dergelijke verbinding bevatten, alsmede werk- wijze voor het bereiden van deze verbindingen.
GB8531666D0 (en) 1985-12-23 1986-02-05 Wyeth John & Brother Ltd Indole derivatives
US4925877A (en) 1986-02-25 1990-05-15 Zaidanhojin Biseibutsu Kagaku Kenkyukai Physiologically active erbstatin analogue compounds and compositions
JP2539504B2 (ja) 1987-03-11 1996-10-02 鐘淵化学工業株式会社 ヒドロキシスチレン誘導体
JPH0674161B2 (ja) 1987-12-25 1994-09-21 株式会社日立製作所 グリーンシートの製造方法
ZA899436B (en) 1988-12-12 1990-08-29 Ciba Geigy Piperidine derivatives
US5007913A (en) * 1989-09-19 1991-04-16 Alcon Surgical, Inc. Apparatus and method for implantation of intraocular lenses
US5116846A (en) 1990-03-28 1992-05-26 Du Pont Merck Pharmaceutical Company N-aralkyl piperidine derivatives as psychotropic drugs
US5169855A (en) 1990-03-28 1992-12-08 Du Pont Merck Pharmaceutical Company Piperidine ether derivatives as psychotropic drugs or plant fungicides
MY110227A (en) 1991-08-12 1998-03-31 Ciba Geigy Ag 1-acylpiperindine compounds.
EP0541486A1 (de) 1991-11-07 1993-05-12 Ciba-Geigy Ag Polycyclische Konjugate
GB9318431D0 (en) 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents
DK0672041T3 (da) 1993-10-01 2002-02-25 Novartis Ag Farmakologisk aktive pyridinderivater og fremgangsmåder til fremstilling deraf
AU7856194A (en) 1993-10-26 1995-05-22 Ciba-Geigy Ag N-benzoyl-4-oxy/thio-2-substituted piperidines as substance-p receptor antagonists
RU2191188C2 (ru) 1994-11-14 2002-10-20 Варнер-Ламберт Компани Производные 6-арилпиридо[2,3-d]-пиримидины и -нафтиридины, фармацевтическая композиция, обладающая ингибирующим действием клеточной пролиферации, вызываемой протеиновой тирозинкиназой, и способ ингибирования клеточной пролиферации
JP3938936B2 (ja) 1995-04-26 2007-06-27 協和醗酵工業株式会社 ラディシコール誘導体
GB9514380D0 (en) 1995-07-13 1995-09-13 Knoll Ag Therapeutic agents
US6077857A (en) 1995-11-13 2000-06-20 Smithkline Beecham Corporation Hemoregulatory compounds
US5707990A (en) 1996-01-30 1998-01-13 Ortho Pharmaceutical Corporation 2-substituted amino and thio alkyl benzoxazine antimicrobial agents
EP0891334A1 (de) 1996-04-03 1999-01-20 Merck & Co., Inc. Inhibitoren von farnesylprotein-transferase
WO1997045119A1 (en) 1996-05-24 1997-12-04 Novartis Ag Use of substance p antagonists for treating social phobia
CA2257950A1 (en) 1996-06-28 1998-01-08 Merck & Co., Inc. Fibrinogen receptor antagonist prodrugs
JP4386967B2 (ja) 1996-07-13 2009-12-16 グラクソ、グループ、リミテッド プロテインチロシンキナーゼ阻害剤としての縮合複素環式化合物
HRP970371A2 (en) 1996-07-13 1998-08-31 Kathryn Jane Smith Heterocyclic compounds
US5977134A (en) 1996-12-05 1999-11-02 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
AU8673598A (en) 1997-08-01 1999-02-22 University Of Florida Neuraminidase inhibitors
EP1051413B1 (de) 1998-01-26 2003-06-04 SmithKline Beecham plc Chinolinderivate als antibakterielles arzneimittel
WO1999037304A1 (en) 1998-01-27 1999-07-29 Aventis Pharmaceuticals Products Inc. SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
US6300341B1 (en) 1998-09-30 2001-10-09 The Procter & Gamble Co. 2-substituted heterocyclic sulfonamides
GB9822440D0 (en) 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
GB9822450D0 (en) 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
EP1140834A1 (de) 1998-12-18 2001-10-10 Du Pont Pharmaceuticals Company Heterozyklische piperidine als modulatoren der aktivität der chemokinerezeptoren
EP1144404A1 (de) 1999-01-20 2001-10-17 Smithkline Beecham Plc Piperidinylchinoline als proteintyrosinkinasehemmer
GB9914486D0 (en) 1999-06-21 1999-08-18 Smithkline Beecham Plc Medicaments
GB9915616D0 (en) 1999-07-05 1999-09-01 Knoll Ag Therapeutic agents
GB9917408D0 (en) 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
GB9917406D0 (en) 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
WO2001007436A2 (en) 1999-07-28 2001-02-01 Aventis Pharmaceuticals Inc. Substituted oxoazaheterocyclyl compounds
SE9902987D0 (sv) 1999-08-24 1999-08-24 Astra Pharma Prod Novel compounds
ES2316383T3 (es) 1999-09-17 2009-04-16 Millennium Pharmaceuticals, Inc. Benzamidas e inhibidores relacionados del factor xa.
US6403610B1 (en) 1999-09-17 2002-06-11 Aventis Pharma S.A. Quinolylpropylpiperidine derivatives, their preparation and the compositions which comprise them
FR2798656B1 (fr) 1999-09-17 2004-12-17 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent
EP1248770A1 (de) 1999-12-16 2002-10-16 Biostream Therapeutics 1,3,4-substituierte piperidin-analoge und deren verwendung zur suchtbehandlung
WO2001053288A1 (en) 2000-01-20 2001-07-26 Eisai Co., Ltd. Novel piperidine compounds and drugs containing the same
SK13072002A3 (sk) 2000-03-17 2003-08-05 Bristol-Myers Squibb Pharma Company Deriváty cyklických beta-aminokyselín ako inhibítory matrixových metaloproteáz a TNF-alfa
WO2001070737A2 (en) 2000-03-20 2001-09-27 Sepracor, Inc. Therapeutic heterocyclic compounds for the treatment of asthma and allergy and use thereof
US6469026B2 (en) 2000-03-24 2002-10-22 Millennium Pharmaceuticals, Inc. Isoquinolone inhibitors of factor Xa
GB0011838D0 (en) 2000-05-17 2000-07-05 Astrazeneca Ab Chemical compounds
US6803369B1 (en) 2000-07-25 2004-10-12 Smithkline Beecham Corporation Compounds and methods for the treatment of neoplastic disease
IL154107A0 (en) 2000-07-26 2003-07-31 Smithkline Beecham Plc Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
WO2002024684A1 (en) 2000-09-21 2002-03-28 Smithkline Beecham P.L.C. Quinoline derivatives as antibacterials
FR2816618B1 (fr) 2000-11-15 2002-12-27 Aventis Pharma Sa Derives heterocyclylalcoyl piperidine, leur preparation et les compositions qui les contiennent
US6603005B2 (en) 2000-11-15 2003-08-05 Aventis Pharma S.A. Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them
GB0031088D0 (en) 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
GB0031086D0 (en) 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
FR2822154B1 (fr) 2001-03-13 2005-10-21 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent
US6602884B2 (en) 2001-03-13 2003-08-05 Aventis Pharma S.A. Quinolylpropylpiperidine derivatives, their preparation, and compositions containing them
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0112836D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
US20030203917A1 (en) 2001-07-25 2003-10-30 Smithkline Beecham Corporation And Smithkline Beecham P.L.C. Compounds and methods for the treatment of neoplastic disease
GB0118238D0 (en) 2001-07-26 2001-09-19 Smithkline Beecham Plc Medicaments
KR100395092B1 (ko) * 2001-07-27 2003-08-21 삼성전기주식회사 무선랜 어댑터
WO2003064421A1 (en) 2002-01-29 2003-08-07 Glaxo Group Limited Aminopiperidine derivatives
AU2003239302A1 (en) 2002-01-29 2003-09-02 Glaxo Group Limited Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
US20040198755A1 (en) 2004-10-07
WO2002096907A1 (en) 2002-12-05
DE60215494T2 (de) 2007-03-15
GB0112836D0 (en) 2001-07-18
EP1392686A1 (de) 2004-03-03
JP2004534780A (ja) 2004-11-18
DE60215494D1 (de) 2006-11-30
US7186730B2 (en) 2007-03-06
ES2275006T3 (es) 2007-06-01
EP1392686B1 (de) 2006-10-18

Similar Documents

Publication Publication Date Title
ATE342901T1 (de) Bicyclische, stickstoffhaltige heterocyclische derivate zur verwendung als antibakterielle mittel
ATE344799T1 (de) Piperidinderivate als antibakterielle mittel
ATE327231T1 (de) Chinolinderivate als antibakterielle mittel
GB0101577D0 (en) Compounds
PE20001112A1 (es) Derivados de quinolina como agentes antibacterianos
ATE304006T1 (de) Aminopiperidinderivate als antibakterielles arzneimittel
ATE479683T1 (de) Antibakterielle mittel
ATE255104T1 (de) Quinolin-derivate und deren verwendung als antibakterielle wirkstoffe
BR0210016A (pt) Heterociclos bicìclicos contendo nitrogênio, para uso como antibacterianos
ATE340171T1 (de) Piperazinderivate zur behandlung bakterieller infektionen
TW200507841A (en) Antibacterial agents
MXPA03000708A (es) Aminopiperidin quinolinas y sus analogos azaisostericos con actividad antibacteriana.
ATE294792T1 (de) Naphthyridine und ihre azaisosteren analoga als antibakterielle mittel
DE60307860D1 (de) Aminocyclohexenchinoline und ihre azaisosterischen analoga mit antibakterieller wirkung
EP1560821B8 (de) Antibakterielle wirkstoffe
ATE411312T1 (de) Chinoline und stickstoffhaltige derivatedavon und deren verwendung als antibakterielle mittel
ECSP993176A (es) Nuevos compuestos y composiciones antibacterianas

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties